Ermolaev Nikita, Rettl René, Willixhofer Robin, Kronberger Christina, Poledniczek Michael, Schmid Lena Marie, Duca Franz, Binder Christina, Eslami Mahshid, Beitzke Dietrich, Loewe Christian, Hacker Marcus, Kammerlander Andreas, Kastner Johannes, Bergler-Klein Jutta, Calabretta Raffaella, Badr Eslam Roza
Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.
Division of Cardiovascular and Interventional Radiology, Department of Biomedical Imaging and Image-Guided-Therapy, Medical University of Vienna, 1090 Vienna, Austria.
J Clin Med. 2025 Apr 26;14(9):2999. doi: 10.3390/jcm14092999.
: Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) often experience significantly reduced functional capacity due to myocardial involvement. Cardiopulmonary exercise testing (CPET) is the gold standard to quantify functional capacity, and Tc-DPD scintigraphy and SPECT/CT have proven to be highly effective tools for diagnostic and disease monitoring. We aimed to investigate the complementary role and correlation between both methods, focusing on their combined potential as a strong prognostic framework for monitoring disease progression and evaluating treatment efficacy. : A total of 44 patients with diagnosed ATTR-CM, who underwent Tc-DPD scintigraphy and SPECT/CT imaging as well as CPET, were included. All patients were divided into two groups based on the median DPD retention index (low DPD uptake: ≤5.0, n = 22; high DPD uptake: >5.0, n = 22). : The mean age was 78 years, with 82% of participants being male. Significant correlations were observed between peak VO and DPD retention index (r = -0.355, = 0.018) as well as between peak VO at anaerobic threshold with DPD retention index (r = -0.391, = 0.009). Interestingly, there was no strong correlation between VE/VCO slope and the retention index. A strong association was identified between cardiac biomarkers and peak VO, specifically for NT-proBNP (r = -0.530, < 0.001) and Troponin T (r = -0.431, < 0.001). : In ATTR-CM, significant correlations were observed between key CPET parameters and quantitative cardiac DPD uptake, which further reflects on disease severity and functional impairment. Our findings highlight the utility of integrating CPET and SPECT/CT for comprehensive patient assessment in ATTR-CM.
转甲状腺素蛋白淀粉样变心肌病(ATTR-CM)患者常因心肌受累而出现功能能力显著下降。心肺运动试验(CPET)是量化功能能力的金标准,而锝-二膦酸盐闪烁扫描(Tc-DPD)和单光子发射计算机断层扫描/计算机断层扫描(SPECT/CT)已被证明是诊断和疾病监测的高效工具。我们旨在研究这两种方法的互补作用及相关性,重点关注它们作为监测疾病进展和评估治疗效果的强大预后框架的联合潜力。
共纳入44例确诊为ATTR-CM且接受了Tc-DPD闪烁扫描、SPECT/CT成像以及CPET的患者。所有患者根据DPD潴留指数中位数分为两组(低DPD摄取:≤5.0,n = 22;高DPD摄取:>5.0,n = 22)。
平均年龄为78岁,82%的参与者为男性。观察到峰值摄氧量(peak VO)与DPD潴留指数之间存在显著相关性(r = -0.355,P = 0.018),以及无氧阈时的peak VO与DPD潴留指数之间存在显著相关性(r = -0.391,P = 0.009)。有趣的是,二氧化碳通气当量(VE/VCO)斜率与潴留指数之间没有强相关性。在心脏生物标志物与peak VO之间发现了强关联,特别是对于N末端脑钠肽原(NT-proBNP,r = -0.530,P < 0.001)和肌钙蛋白T(r = -0.431,P < 0.001)。
在ATTR-CM中,观察到关键CPET参数与心脏DPD定量摄取之间存在显著相关性,这进一步反映了疾病严重程度和功能损害。我们的研究结果强调了在ATTR-CM中整合CPET和SPECT/CT进行全面患者评估的实用性。